HIRAK PARIKH

Hirak Parikh is a pivotal Associate at Johnson & Johnson Innovation, a strategic arm dedicated to identifying, nurturing, and investing in the most promising healthcare and life science companies globally. In his role, Hirak is instrumental in the rigorous process of sourcing, evaluating, and executing strategic investments that align with Johnson & Johnson's expansive vision for improving human health.

His day-to-day responsibilities involve deep dives into emerging technologies, conducting comprehensive market analyses, and performing meticulous due diligence on potential investment targets. Hirak works closely with entrepreneurs and scientific leaders, assessing the scientific merit, commercial viability, and strategic fit of innovative solutions that could transform patient care. He also supports the existing portfolio companies, helping them navigate challenges and accelerate their growth within the complex healthcare ecosystem.

Johnson & Johnson Innovation's investment thesis is broad yet focused, encompassing a wide spectrum of healthcare sectors. Hirak Parikh's work primarily contributes to investments across pharmaceuticals, medical devices, consumer health, and digital health solutions. This includes pioneering advancements in areas such as oncology, immunology, neuroscience, cardiovascular and metabolic diseases, as well as surgical technologies, vision care, and consumer wellness products. He is particularly keen on disruptive technologies that leverage data science, artificial intelligence, and precision medicine to create personalized and more effective healthcare interventions.

While specific details of his early career are not publicly detailed, Hirak Parikh likely brings a robust background in science, business, or finance, often a prerequisite for roles within corporate venture capital. Professionals in his position typically possess a strong analytical mindset, a deep understanding of scientific principles, and a keen business acumen developed through prior experience in biotech startups, pharmaceutical R&D, management consulting, or traditional venture capital firms. This multidisciplinary expertise allows him to bridge the gap between scientific discovery and commercial success.

As an Associate, Hirak contributes significantly to the collective success of Johnson & Johnson Innovation's investment portfolio. While individual deal leads are often attributed to senior partners, Hirak's analytical contributions and strategic insights are crucial in the evaluation and ongoing support of numerous groundbreaking companies. His work helps ensure that Johnson & Johnson Innovation continues to back ventures that have the potential to deliver significant impact on global health challenges, fostering a pipeline of innovation that complements J&J's internal R&D efforts.

Hirak Parikh's dedication to advancing healthcare innovation through strategic investment underscores his commitment to making a tangible difference in the lives of patients worldwide. His role at Johnson & Johnson Innovation is vital in shaping the future of medicine and health technology.